United States takes the 51% of the fund, followed by Denmark (18%) and Japan (10%).
If constipation remains severe despite those interventions, or if you develop complications like hemorrhoids or fissures, discuss dose reduction with your provider
By staying hydrated, choosing bland foods, and eating smaller portions, you can navigate this adjustment period with minimal disruption to your daily life
What remains most novel about GLP-1 medications is that they target underlying biological drivers of energy intake and metabolic regulationfactors closely tied to chronic disease riskrather than simply promoting short-term weight reduction, and may, in the long run, contribute to lower health insurance costs by treating related comorbidities, even as they may impact patient longevity and, thus, how life insurance treats these drugs
On April 29, 2025, a press release hailed the Novo Nordisk tie-up for "affordable access" to semaglutide, calling it "high-quality" and "personalized." Dudum said it tackled shortages while "prioritizing safety." The Q1 earnings call echoed this, with Dudum bragging about "innovative partnerships" for consumer choice